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Abstract
The development of the brain requires the exquisite coordination of progenitor proliferation and 
differentiation to achieve complex circuit assembly. It has been suggested that glycogen synthase 
kinase 3 (GSK-3) acts as an integrating molecule for multiple proliferation and differentiation 
signals because of its essential role in the RTK, Wnt and Shh signaling pathways. We created 
conditional mutations that deleted both the α and β forms of GSK-3 in mouse neural progenitors. 
GSK-3 deletion resulted in massive hyperproliferation of neural progenitors along the entire 
neuraxis. Generation of both intermediate neural progenitors and postmitotic neurons was 
markedly suppressed. These effects were associated with the dysregulation of β-catenin, Sonic 
Hedgehog, Notch and fibroblast growth factor signaling. Our results indicate that GSK-3 signaling 
is an essential mediator of homeostatic controls that regulate neural progenitors during mammalian 
brain development.
GSK-3 is a serine-threonine kinase with established roles in receptor tyrosine kinase and 
Wnt/Frizzled signaling. In mammals, the GSK-3 family consists of two members, GSK-3α 
and GSK-3β, which have 98% sequence identity in their kinase domains. Recent studies that 
have mostly used pharmacological approaches have suggested that GSK-3 is important in an 
array of settings including regulation of transcription factor levels in multiple signaling 
pathways, cell polarity and neurotransmitter signaling1–3. Recently, pharmacological 
evidence has implicated GSK-3 signaling in the regulation of embryonic stem cell self-
renewal4–6. Furthermore, it has been suggested that the Deleted in Schizophrenia (DISC1), 
which has been implicated in some familial cases of schizophrenia and depression, regulates 
Reprints and permissions information is available online at http://www.nature.com/reprintsandpermissions/.
Correspondence should be addressed to W.D.S. (wsnider@med.unc.edu). 
Note: Supplementary information is available on the Nature Neuroscience website.
AUTHOR CONTRIBUTIONS
W.-Y.K. designed and conducted most of the experiments, analyzed the data, and co-wrote the paper. X.W. contributed to the in vitro 
experiments and ideas. Y.W. conducted western blotting and contributed technical assistance. B.W.D. and S.P. generated the GSK-3 
mutant lines. J.R.W. contributed to experimental design, provided intellectual guidance and co-wrote the paper. W.D.S. supervised the 
work, contributed to the experimental design, provided intellectual guidance and co-wrote the paper.
Nat Neurosci. Author manuscript; available in PMC 2017 February 27.
Published in final edited form as:



















neural progenitor proliferation and may act in part via regulation of GSK-3 activity7. These 
observations raise the question of how GSK-3 functions in relation to neural progenitor self-
renewal and neurogenesis during brain development.
Development of the brain requires exquisite coordination of progenitor proliferation and 
differentiation to achieve optimized functional potential. Recently, multiple signaling 
pathways, including Wnts, fibroblast growth factors (FGFs), Sonic Hedgehog (Shh) and 
Notch, have been identified as regulating neural progenitors8. However, the manner in which 
these signals are coordinated to achieve exquisite spatial and temporal control over 
neurogenesis is unknown. GSK-3s are uniquely well-positioned to coordinate multiple 
proliferation and differentiation signals because they potentially regulate critical nodes in 
each of these pathways. Inhibition of GSK-3 is critical to canonical Wnt signaling leading to 
increased β-catenin levels in all of the cell types studied to date1. Furthermore, GSK-3 is 
inhibited downstream of FGF signaling via phosphatidylinositol-3 kinase (PI3K)9. Several 
recent studies in cell lines have demonstrated GSK-3 regulation of Myc family proteins via 
the PI3K pathway10–13. In Drosophila, it is known that the GSK-3 homolog Shaggy 
regulates Hedgehog signaling14. Finally, several studies in cell lines have demonstrated that 
GSK-3 inhibition modulates the Notch pathway15–17. To date, however, the effects of 
deleting GSK-3 specifically in neural progenitors on signaling via these pathways and on 
progenitor self-renewal and subsequent brain development have not been determined.
We used a conditional knockout strategy in a Gsk3a null background to specifically target 
Gsk3b in the developing nervous system. We found that GSK-3–deficient progenitors were 
locked into the radial progenitor phase, as generation of both intermediate neural progenitors 
(INPs) and postmitotic neurons was markedly suppressed. Our findings suggest that GSK-3 
deletion removes homeostatic controls on neural progenitors, shifting the balance toward 
self-renewal and away from neurogenesis.
RESULTS
GSK-3 deletion markedly enhances progenitor proliferation
To investigate the functions of GSK-3 in the developing mammalian nervous system, we 
generated Gsk3a−/− (Gsk3a null) and Gsk3bloxP/loxP mice and crossed these with a well-
characterized nestin-cre line that drives expression of Cre recombinase in CNS progenitors 
from about embryonic day 10 (E10)18,19. Gsk3a null mice that harbored an exon 2 deletion 
and Gsk3bloxP/loxP mice were generated by flanking exon 2 with loxP sites (Supplementary 
Fig. 1)20,21. Neither Gsk3a null nor Gsk3bloxP/loxP; nestin-cre mice had major brain 
developmental malformations (W.-Y.K. and W.D.S., unpublished observations)22. Western 
blots showed that the α and β forms of GSK-3 were eliminated in the developing brains of 
Gsk3a−/−; GSK Gsk3bloxP/loxP; nestin-cre mice (Supplementary Fig. 1). Compared with the 
control littermates (Gsk3a+/−; Gsk3bloxP/+; nestin-cre), Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre 
mice had bigger heads (Supplementary Fig. 1) at every developmental stage from E12.5 
until they died at P0. Brains from control mice had smooth and straight cortices in coronal 
sections at E13.5 (Supplementary Fig. 1), whereas the brains of Gsk3a−/− Gsk3bloxP/loxP; 
nestin-cre mice were markedly convoluted. Gsk3a−/− Gsk3bloxP/loxP; nestin-cre brains also 
showed substantially enlarged ventral brain areas, including the ganglionic eminence and 
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ventral thalamus (Supplementary Fig. 1). We measured the ventricular apical surface lengths 
and found a 2.7-fold increase in GSK-3–deleted brains compared with control brains 
(Supplementary Fig. 1).
To explore the basis of the convoluted cortex, we assessed neural progenitors in the Gsk3a
−/−; Gsk3bloxP/loxP; nestin-cre brain using an antibody to Sox2, a neural progenitor marker. 
In control brains at E13.5, Sox2-positive progenitors were distinctly distributed surrounding 
the ventricles (Fig. 1a). We also observed Sox2 expression in a limited part of the dorsal 
ganglionic eminence. In Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains, Sox2-positive neural 
progenitor pools were massively expanded (Fig. 1a). At the level of ganglionic eminence, 
this expansion was also prominent in ventral forebrain. We observed this progenitor 
expansion at every rostro-caudal level that we examined, including spinal cord (Fig. 1a).
To further assess this hyperproliferation, we measured the proportion of cells in various cell-
cycle phases at E13.5. Twice as many cells were positive per coronal section for the mitotic 
marker phosphohistone H3 in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cerebral cortex compared 
with controls (Fig. 1b,c and Supplementary Fig. 2). Western blotting confirmed that 
phospho-histone H3 expression was markedly increased (Supplementary Fig. 2). We then 
assessed the numbers cells in S phase after a short-term BrdU pulse. The number of BrdU-
positive S phase cells was also increased (Fig. 1b,c and Supplementary Fig. 2). These results 
indicate that many more cells were undergoing division in Gsk3a−/−; Gsk3bloxP/loxP; nestin-
cre brains than in controls at E13.5. To further identify the underlying causes of the 
expansion of the progenitor pool, we investigated cell-cycle length and re-entry. The number 
of Ki67 and BrdU double-positive cells after short and long BrdU pulses in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre cortex was increased (Fig. 1c), indicating both a shortening of the 
cell cycle and increased cell-cycle re-entry. Immunostaining and western blotting with an 
antibody to activated caspase-3 revealed that levels of apoptosis were not significantly 
different between control and mutant cortex at E13.5 (P < 0.01; Fig. 1c and Supplementary 
Fig. 2). Taken together, these results indicate that the expanded progenitor pool in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre brain is the result of increases in cell-cycle rate and re-entry, but 
not of enhanced progenitor survival.
GSK-3 deletion strongly Inhibits neurogenesis
To assess the progression of the radial progenitors to INPs, we immunostained cerebral 
cortex samples using an antibody to Tbr2, a specific marker for INPs23. To our surprise, we 
found that the number of Tbr2-positive cells was reduced by 64% (±2.7%) in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre cortices (Fig. 2a). Western blotting showed that the level of Tbr2 
in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain was markedly decreased (Fig. 2b). Our results 
indicate that GSK-3 activity is required to regulate the conversion of Sox2-positive radial 
progenitors into INPs during cortical development.
We next examined the number of neurons in both control and mutant sections using 
immunostaining with an antibody to Tuj1 that recognizes postmitotic neurons. The numbers 
of Tuj1–positive neurons were decreased by about 60% in Gsk3a−/−; Gsk3bloxP/loxP; nestin-
cre cortical sections (Fig. 3). We observed similar decreases with Tbr1 and NeuN, two 
commonly used neuronal markers (Fig. 3b–d). These morphological results were confirmed 
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by western blotting. The levels of the neuronal makers Tuj1, MAP2, SMI32 and NeuN in 
Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain tissue were all reduced by 50–70% (Fig. 3e,f). In 
contrast, the progenitor markers Nestin and Pax6 were upregulated by 100–200%. Together, 
these results indicate that GSK-3 is required for proper regulation of neuro-genesis in the 
developing mouse brain.
To assess the effects on neurogenesis over time, we examined Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre brains at multiple rostro-caudal levels at E15.5 (Fig. 4). Notably, we observed that 
there was massive expansion of the area filled with Sox2-positive cells throughout the 
telencephalon in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cortical wall in comparison with 
controls, where Sox2-positive progenitors were restricted to regions surrounding the 
ventricles (Fig. 4a–d). Neurogenesis in GSK-3 mutant brains at this age was strongly 
suppressed, as marked by Tuj1 staining (Fig. 4e,f). Thus, inhibition of neurogenesis is 
persistent in the absence of GSK-3 signaling.
One implication of our findings is that GSK-3 activity toward substrates that influence 
proliferation may be upregulated as the progenitor proliferation diminishes and as 
neurogenesis proceeds. To assess this idea in a general way, we measured the 
phosphorylation levels of c-Myc and β-catenin, GSK-3 targets, at three developmental 
stages, E13, E15 and E17. Both phospho–c-Myc and phospho–β-catenin levels in brain 
lysates were increased with increasing embryonic age (Supplementary Fig. 3), suggesting 
that GSK-3 activity toward the proliferation regulators c-Myc and β-catenin is suppressed 
during the period of active progenitor proliferation and increased at later stages.
Activation of β-catenin, Shh and Notch signaling
To determine whether Wnt signaling is involved in the expansion of the progenitor pool in 
Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains, we first examined the expression levels and the 
distribution patterns of β-catenin. In controls, β-catenin was highly enriched along the apical 
surface (Fig. 5a). However, in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains, β-catenin was 
highly expressed throughout the thickness of the developing cortex (Fig. 5a). We also 
observed a similar loss of the normal spatial expression pattern and an increase in the levels 
of β-catenin in the spinal cord (Supplementary Fig. 4). At the single-cell level, we found an 
increased level of β-catenin in both the nucleus and the cytosol in GSK-3 mutant brains (Fig. 
5a), indicating accumulation and translocation of β-catenin from the cytosolic compartment 
to the nucleus. Western blots showed that total levels of β-catenin and its transcriptional 
targets Axin2 and c-Jun were increased in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains (Fig. 
5b). Together, these data indicate that β-catenin is markedly dysregulated in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre neural progenitors and suggest that β-catenin/TCF/LEF1 signaling 
is hyperactive in these cells.
To further investigate the mechanisms responsible for the expanded progenitor pool, we 
examined Shh signaling. We first examined overall levels of Shh downstream effectors, Gli1 
and Gli2 proteins in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains at E14.5. Western blots 
showed that levels of Gli1 and Gli2 were markedly increased, whereas levels of Gli3 were 
unchanged (Fig. 5). Gli1 has been demonstrated to be a direct transcriptional target of Gli2 
in neural and non-neural systems24. Therefore, we determined the distribution patterns of 
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Gli1 mRNAs in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains using in situ hybridization. Gli1 
was strongly expressed in the ventricular/subventricular zone of GSK-3 mutant dorsal 
telencephalon, whereas there was little expression in control dorsal telencephalon (Fig. 5d). 
Furthermore, we found a massive expansion of Gli1 expression in mutant ventral 
telencephalon (Fig. 5d). Patched, a transcriptional target of Shh signaling24, was also 
markedly upregulated, particularly in dorsal regions of the ganglionic eminence (Fig. 5d). 
The increased levels of Shh components were not associated with Shh protein levels, as no 
changes were found in Shh expression between control and GSK-3–deleted brain samples 
(Supplementary Fig. 5). To test whether the increases in the levels of Shh components are 
functionally relevant, we knocked downed Gli1 in dissociated Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre progenitors using small interfering RNA to Gli1. The siRNA decreased the 
progenitor proliferation by about 35% compared with controls (Supplementary Fig. 5). 
These data indicate that Shh signaling is constitutively activated in Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre brains and that Shh signaling is important in mediating GSK-3 deletion effects.
Finally, to determine whether there may be abnormal activation of Notch signaling in Gsk3a
−/−; Gsk3bloxP/loxP; nestin-cre brains, we examined the expression level and distribution 
pattern of Hes1, a Notch downstream mediator. Hes1 expression is normally restricted to the 
ventricular and subventricular zones (Fig. 6a). However, we found that Hes1 was distributed 
throughout the width of the cerebral cortical wall of GSK-3 mutants. The overall levels of 
Hes1 and Hes5 were also substantially increased in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre 
brain lysates (Fig. 6b). The widespread distribution and upregulation of Hes1 suggests that 
the Notch pathway is activated in the developing cortex of Gsk3a−/−; Gsk3bloxP/loxP; nestin-
cre embryos. To address this possibility, we measured the amount of cleaved intracellular 
domain of Notch (NICD, activated form of Notch) that was present. We found that, 
compared with control brains, the amount of NICD in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre 
brains was markedly increased (Fig. 6c). To assess the increase in Notch signaling is 
functionally relevant, we treated GSK-3–deleted progenitors with the gamma secretase 
inhibitor N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S- phenylglycine t-butyl ester (DAPT). 
This treatment reduced the hyperproliferation and increased the number of MAP2-positive 
neurons (Supplementary Fig. 6). We conclude that inactivation of endogenous GSK-3 
enhances Notch signaling, which then inhibits neurogenesis in Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre mice.
Both constitutive and targeted activation of β-catenin enhances the proliferation of neural 
progenitors25,26. These findings raise the questions of whether the effects of GSK-3 deletion 
that we observed are entirely mediated by increased levels of β-catenin. To address this 
issue, we inhibited β-catenin signaling by transfecting dissociated Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre cortical progenitors with a dominant- negative TCF (dnTCF) construct that lacks 
the N-terminal sequences required for β-catenin binding27. Overexpression of dnTCF only 
partially inhibited proliferation of GSK-3–deleted progenitors, reducing proliferation 
markers by about 50% (Fig. 6d,e). The percentage of proliferating cells was still almost 
twice as high as that of controls (Supplementary Fig. 6). Thus, a substantial fraction of 
GSK-3–deleted progenitors continued to proliferate when β-catenin signaling was 
suppressed. Notably, inhibition of Notch signaling by transfection of a dominant-negative 
Hes1 (dnHes1) also resulted in reductions of progenitor proliferation by around 50% (Fig. 
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6d,e). However, inhibition of both β-catenin and Notch signaling reduced proliferation in 
GSK-3–deleted cells to levels below 5% (Fig. 6d,e). These results are consistent with the 
idea that independent regulation of β-catenin and Notch signaling mediate GSK-3’s effects.
GSK-3 regulation of c-Myc downstream of FGF/PI3K
Myc family proteins are critical for the regulation of proliferation in multiple settings and 
GSK-3 has been shown to directly regulate the stability of both c-Myc and the related family 
member N-Myc in cell lines10. We stained Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre progenitors 
with an antibody to c-Myc and found that there was a massive accumulation of c-Myc 
proteins in the nucleus (Fig. 7a). Western blots confirmed the major increase of c-Myc and 
N-Myc in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain samples that we observed (Fig. 7b). 
GSK-3 phosphorylation of c-Myc (and N-Myc) at T58 is thought to promote c-Myc 
degradation through ubiquitin-proteasome machinery. We found that T58 phosphorylation 
was almost completely abrogated in GSK-3 mutant brain samples, as predicted (Fig. 7b). To 
test whether the increase in c-Myc levels is functionally relevant, we inhibited c-Myc 
function in dissociated Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre progenitors with a dominant–
negative c-Myc (dnc-Myc) construct in a procedure similar to the one outlined above for β-
catenin. Overexpression of dnc-Myc decreased progenitor proliferation by 41 ± 5% 
compared with a green fluorescent protein (GFP) overexpression control.
GSK-3 regulation of Myc protein stability is thought to occur downstream of PI3K 
signaling. A logical candidate to regulate this signaling would be the FGFs, which are 
known to regulate progenitor proliferation in the developing telencephalon via receptor 
tyrosine kinases8. Therefore, we examined the possibility that GSK-3 mediates FGF-PI3K 
signaling in the regulation of neural progenitor proliferation. We assessed progenitor 
proliferation in control and GSK-3–deficient cortical cultures after treatment with FGF2 
and/or LY294002. As expected, addition of FGF2 increased progenitor proliferation in 
control cultures (data not shown). Treatment with LY294002 decreased the numbers of 
BrdU-positive proliferating progenitors in FGF2-treated control cultures by more than 50% 
(Fig. 7c,d). Notably, the inhibitory effects of LY294002 were completely suppressed in 
Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cortical cultures.
We next assessed c-Myc levels in cortical cultures while inhibiting PI3K and stimulating 
FGF. Treatment of control cortical cultures with LY294002 substantially decreased c-Myc 
levels (Supplementary Fig. 7). As expected, phosphorylation of c-Myc at T58 and GSK-3β 
at S9 were increased and decreased, respectively. These results suggest that inhibition of 
PI3K decreases c-Myc levels by enhancing GSK-3 activity. To address this possibility, we 
performed the same experiments in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cortical cultures. 
The decrease in c-Myc levels that we observed with LY294002 treatment was abolished in 
the lysates of GSK-3β–deleted cultures (Fig. 7e). To assess the potential regulation of c-Myc 
levels by FGF2, we treated cortical cultures with FGF2. Treatment with FGF2 markedly 
upregulated c-Myc and this was inhibited by LY294002 (Fig. 7f). The increase of c-Myc in 
GSK-3–deficient cortical cells was not affected by treatment with either FGF2 or FGF2 and 
LY294002 (Fig. 7f). Taken together, these results strongly suggest that GSK-3 mediates 
FGF-PI3K regulation of c-Myc.
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Multiple studies have shown that appropriate apical-basal polarity of progenitors is required 
for normal neurogenesis28. To address progenitor polarity, we stained brain tissues with 
antibodies against multiple cell polarity and adhesion markers including PKCζ, cadherin, 
actin, APC and EB1. The polarized apical concentrations of the markers were significantly 
reduced in the cortex of Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre animals (Supplementary Fig. 
8). These results demonstrate that GSK-3 signaling is essential for apical-basal polarity in 
the developing cortex and suggest that GSK-3 may control progenitor proliferation in part by 
organizing cellular polarity.
DISCUSSION
GSK-3 is an important molecular regulator of neurogenesis
We found that deletion of GSK-3 massively expanded the radial progenitor pool. The 
elimination of either GSK-3 family member alone or the elimination of three Gsk3 alleles 
had no obvious effect. This suggests that a major reduction of GSK-3 signaling is required to 
remove critical GSK-3–mediated homeostatic controls during embryonic brain development.
Determination of the mitotic index with phospho-histone H3, BrdU and Ki67 labeling 
indicated that premature re-entry and shortening of the cell cycle occurred in progenitors in 
Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre mice. Shortened cell cycle has previously been 
implicated in reduced responsiveness to differentiation signals and it has been suggested that 
cell-cycle regulation is an important control point for mechanisms that account for 
differences in neuron number between rodents and primates29. In contrast with the 
expansion of Sox2-positive radial progenitors, generation of neurons and INPs was markedly 
reduced in the absence of GSK-3. Thus, neural differentiation was arrested at the radial 
progenitor stage. The effects of GSK-3 deletion on proliferation and differentiation that we 
observed suggest that temporal and spatial regulation of GSK-3 activity during nervous 
system development is required to terminate proliferation and allow differentiation at just the 
right moment to yield the correct number of neurons. Our results raise the possibility that 
regulation of the activity of a single kinase provides a powerful and simple mechanism for 
controlling neuron number.
GSK-3 deletion removes multiple homeostatic controls
The extent to which the multiple mechanisms that are known to regulate neural progenitors 
operate independently or are coordinately regulated is unclear. GSK-3 has the, to the best of 
our knowledge, unique potential to control each of these critical homeostatic mechanisms.
Dysregulation of β-catenin levels is likely to be important for the hyperproliferation of 
progenitors that we observed. Our findings are entirely consistent with the notion that 
appropriate regulation of β-catenin is critical for the control of progenitor proliferation in 
multiple regions of the developing nervous system7,25,26,30–32. Shh signaling is also affected 
by GSK-3 deletion. Our results suggest that there is a mammalian counterpart of the 
Drosophila GSK-3 homolog Shaggy, which regulates cubitus interruptus (a homolog of 
mammalian Gli proteins) in the Drosophila Hedgehog signaling pathway14. The increased 
proliferation and regulation of Shh signaling components observed in the ventral 
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telencephalon of GSK-3–deleted mutants strongly suggest that GSK-3 is a critical mediator 
of Shh signaling in this region. GSK-3 is therefore a candidate for integrating Wnt/β-catenin 
and Shh signaling pathways, both of which are known to control neurogenesis in the ventral 
telencephalon32.
Our data also indicate that Notch signaling is increased in GSK-3–deficient brains. Notch 
signaling is known to be important for the maintenance of ‘stemness’ and the identity of 
radial glial cells during development33–35. Notably, Notch signaling levels distinguish radial 
progenitors from INPs that have attenuated canonical Notch signaling34. Our results are 
consistent with the idea that high levels of Notch signaling in Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre cells suppress neurogenesis at the stage of radial progenitors as they self-renew 
and that few cells progress to become Tbr2-positive INPs.
Potential interactions among GSK-3–regulated pathways
An important issue is whether GSK-3 regulation leads to a hierarchy of signaling 
mechanisms that regulate progenitor proliferation or whether multiple GSK-3–regulated 
mechanisms each contribute independently to the final outcome. There is some evidence that 
β-catenin can influence Notch signaling and can be regulated by the FGF pathway9. 
However, we doubt that stabilization of β-catenin alone fully accounts for the effects that we 
describe here and suggest that several other GSK-3–regulated mechanisms exert independent 
effects. Elimination of β-catenin in neural progenitors reduces, but does not eliminate, 
progenitor proliferation in vivo30,32. Our data indicate that overexpression of dnTCF only 
partially inhibits proliferation in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre neural progenitors in 
vitro. These results suggest that GSK-3 deletion may result in effects on Notch signaling that 
are independent of β-catenin. Several studies have suggested that GSK-3 may directly 
regulate Notch signaling via phosphorylation of Notch1 or Notch2, or regulate the actions of 
the gamma secretase presenillin-1 (refs. 15–17). However, all of this work has been carried 
out in cell lines and the importance of these findings in vivo is unclear.
Finally, our data indicate that GSK-3 strongly regulates Myc family proteins and that FGF 
regulation of c-Myc via PI3K signaling is disrupted by GSK-3 deletion. Myc family proteins 
are critical for the regulation of proliferation in multiple settings and a Myc family member, 
N-Myc, is known from mouse genetic studies to be required for the maintenance of neural 
progenitor proliferation in cerebellum and cortex10. Because c-Myc is thought to be a 
transcriptional target of β-catenin36,37, at least some of the observed increase of c-Myc in 
GSK-3–deleted progenitors may be attributable to β-catenin effects. However, we found 
another mechanism of c-Myc regulation, in which FGF-PI3K controls c-Myc levels via 
GSK-3. Our findings are consistent with work in cell lines demonstrating that GSK-3 
signaling can directly regulate the stability of Myc family proteins via PI3K signaling11–13. 
Indeed, we found that GSK-3 phosphorylation of c-Myc at T58, which is thought to be 
important for its stability, is regulated by PI3K. This FGF–PI3K–GSK-3 regulation of Myc 
protein stability in neural progenitors is likely to be critical for determining its effects, as the 
half-life of Myc protein in cell lines is extraordinarily brief, on the order of 20 min38.
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DAPT (Calbiochem), recombinant human basic FGF2 (Sigma), recombinant human 
epidermal growth factor (EGF) (R&D system), B27 supplements (Invitrogen), N2 
supplement (Invitrogen), BrdU (Sigma) and LY294002 (Cell Signaling) were purchased 
from the companies indicated. Plasmids encoding wild-type and a constitutively active β-
catenin were generously provided by B. Vogelstein (Johns Hopkins University). Dominant-
negative TCF, Hes1 and c-Myc were generous gifts from A. Chenn (Northwestern 
University), A. Strom (Karolinska Institute) and H. Sugimura (Hamamatsu University), 
respectively. Gli1 siRNAs were obtained from Invitrogen.
Mice
Mice were cared for according to animal protocols approved by the Institutional Animal 
Care and Use Committees of the University of North Carolina and University of Toronto. 
Gsk3a−/− mice were engineered to harbor an exon 2 deletion20. Gsk3bloxP/loxP mice were 
generated so that exon 2 is flanked by loxP sites21. Nervous system–specific conditional 
GSK-3 double-knockout mice (Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre) were generated by 
mating Gsk3a−/−, Gsk3bloxP/loxP and nestin-cre mice18. Littermate Gsk3a+/−; Gsk3bloxP/+; 
nestin-cre mice served as controls.
Immunohistochemistry
Immunohistochemical labeling of embryonic brain sections or dissociated neural cells was 
performed as previously described22. For primary antibodies, we used rabbit antibody to 
Sox2 (Chemicon), mouse antibody to Nestin (BD biosciences), rabbit antibody to Tbr1 
(Chemicon), rabbit antibody to Tbr2 (Abcam), rabbit antibody to phospho-histone H3 
(Upstate Biotech), mouse antibody to BrdU (Sigma), rabbit antibody to Ki67 (Covance), 
rabbit antibody to caspase 3 (Cell Signaling), rabbit antibody to β-catenin (Cell Signaling), 
mouse antibody to Tuj1 (Sigma), mouse antibody to tubulin (Sigma), mouse antibody to 
NeuN (Chemicon), rabbit antibody to PKCζ (Cell signaling), rabbit antibody to cadherin 
(Cell Signaling), mouse antibody to actin (Sigma), rabbit antibody to APC (gift from K. 
Neufeld, University of Kansas), mouse antibody to EB1 (Sigma), mouse antibody to γ-
tubulin (Sigma), rabbit antibody to Hes1 (Santa Cruz), rabbit antibody to c-Myc (Cell 
Signaling) or mouse antibody to GSK-3β (BD Biosciences). Appropriate Cy2-, Cy3- or 
Alexa dye–conjugated secondary antibodies (Jackson ImmunoResearch, Molecular Probes) 
were used to detect primary antibody binding. DAPI (Sigma) or Draq5 (Molecular probes) 
was used as nuclear counterstains.
Morphometry
For the quantification of brain size and ventricular apical surface length, we imaged ten 
different cresyl violet–stained brain sections at periodic distances along the rostro-caudal 
axis. The area of each section was defined using the Freehand selection tool in ImageJ (US 
National Institutes of Health). The calculated ImageJ values were averaged and the result 
was recalculated as relative changes versus control. The same brain sections were used to 
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measure ventricular apical surface lengths of control and Gsk3a−/−; Gsk3bloxP/loxP; nestin-
cre brains. Ventricular apical surface length was defined using the Freehand line selection 
tool in ImageJ.
For cell counts, images were taken with a Zeiss LSM510 confocal microscope and a Nikon 
Eclipse epifluorescence microscope. For image analysis, the Zeiss LSM510 image browser 
and Metamorph software (Molecular Devices) were used. The numbers of neural progenitors 
and neurons positive for BrdU, phospho-histone H3, Ki67, Sox2, MAP2, Tuj1, Tbr1 or 
NeuN were obtained as previously described25,39.
BrdU administration and quantification of mitosis
For proliferation assays, intraperitoneal injection was performed into pregnant mice at E11–
14. BrdU (20 mg per kg of body weight, dissolved in 0.9% saline, wt/vol) was administered 
either 24 h or 30 min before the mouse was killed for transient assays.
The mitotic index is a ratio of the number of phospho-histone H3–positive cells to the 
number of DAPI-stained cells per field. To analyze the BrdU labeling index and cell-cycle 
re-entry, we exposed E13 control and Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre mice to BrdU. 
Then brain slices were immunostained with antibodies to BrdU and Ki67. The BrdU 
labeling index is the fraction of progenitor cells (Ki67 and BrdU double positive) to the 
number of BrdU-positive cells after a 30-min BrdU pulse label. For the analysis of cell-cycle 
re-entry, mice were exposed to a single-pulse BrdU label for 24 h. The fraction of cells 
labeled with BrdU and Ki67 relative to the total number of BrdU-positive cells after a 24-h 
pulse label was determined.
Western blotting
Extracts from E13.5 telencephalon was prepared using RIPA buffer and the protein content 
was determined by a Bio-Rad Protein Assay system. Proteins were separated on 3–8% or 4–
12% SDS-PAGE gradient gels and transferred onto nitrocellulose membrane. The membrane 
was incubated with mouse antibody to GSK-3 (Invitrogen), rabbit antibody to phospho–
GSK-3β (Cell signaling), mouse antibody to actin (Sigma), rabbit antibody to phospho-
histone H3 (Upstate), rabbit antibody to activated caspase 3 (Cell Signaling), rabbit antibody 
to Tbr2 (Abcam), mouse antibody to Tuj1 (Sigma), mouse antibody to MAP2 (Chemicon), 
mouse antibody to NeuN (Chemicon), mouse antibody to Pax6 (Iowa Hybridoma Bank), 
mouse antibody to Nestin (BD Biosciences), rabbit antibody to β-catenin (Cell Signaling), 
SMI32 (Sternberger Immunocytochemicals), rabbit antibody to c-Myc (Cell Signaling), 
mouse antibody to N-Myc (Santa Cruz), rabbit antibody to c-Jun (Cell Signaling), rabbit 
antibody to Hes1 (Santa Cruz), rabbit antibody to NICD (Cell Signaling), rabbit antibody to 
Gli1 (Cell Signaling), rabbit antibody to Gli2 (Abcam), rabbit antibody to Gli3 (Santa Cruz), 
rabbit antibody to phospho-AKT (Cell Signaling), rabbit antibody to phospho-MEK (Cell 
Signaling), rabbit antibody to phospho-ERK (Cell Signaling), rabbit antibody to GluR (Cell 
Signaling) or rabbit antibody to GAPDH (Cell Signaling) at 4 °C overnight. As secondary 
antibodies, we used donkey antibody to mouse or rabbit IgG conjugated to horseradish 
peroxidase (Amersham). ECL reagents (Amersham) were used for immunodetection.
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For quantification of band intensity, blots from three independent experiments for each 
molecule of interest were used. Signals were measured using ImageJ software and 
represented by relative intensity versus that of control. GAPDH was used as an internal 
control to normalize band intensity.
Progenitor cultures
Cerebral cortex from E11–14 mice dorsal telencephalon was isolated and dissociated with 
trituration after trypsin/EDTA treatment. Then, the cells were plated onto poly-D-lysine/
laminin–coated coverslips and cultured for 2 d in the medium containing neurobasal 
medium, B27 and N2 supplements, FGF2 (10 ng ml−1), and EGF (10 ng ml−1). For 
differentiation of neural progenitors, the medium containing FGF2 and EGF was removed 
and replaced by neurobasal medium with 5% serum (vol/vol), B27 and N2 supplements. To 
assess the numbers of proliferating progenitors and differentiated neurons, we carried out 
immunostaining and morphometry using antibodies to Ki67, phospho-histone H3 and 
MAP2, as described above. More than 20 random microscopic fields (10× and 20×) were 
analyzed for each condition.
For capturing images of the cultures, we used Metamorph software and a Hamamatsu Orca 
ER CCD camera attached to a Nikon Eclipse microscope. All image analysis for the 
measurement of proliferating cells was done with IPLab software (Scanalytics) or 
Metamorph software.
Electroporation
Mouse cortical progenitors were transfected with various plasmids as described 
previously22. First, embryonic cortices were dissociated and suspended in 100 μl of Amaxa 
electroporation buffer with 2–10 μg of plasmid DNA. Then, suspended cells were transferred 
to an Amaxa electroporation cuvette and electroporated with an Amaxa Nucleofector 
apparatus set on the G-13 program. After electroporation, cells were plated onto coated 
coverslips and the medium was changed 4 h later to remove the remnant transfection buffer.
dnTCF and dnc-Myc lack the β-catenin–binding domain and transactivation domain, 
respectively. dnHes1 has a mutated DNA-binding domain. A ratio of the number of Ki67 
and GFP double-positive cells to the number of GFP-positive transfected cells was 
determined using the sampling methods outlined above.
In situ hybridization
For riboprobe synthesis, we used the pBSII plasmids containing Gli1 and Patched (A. 
Joyner, Memorial Sloan-Kettering Cancer Institute). A 1,600-bp EcoRI fragment containing 
a zinc-finger domain was used to generate antisense Gli1 riboprobe. Patched riboprobe was 
synthesized from an 841-bp EcoRI fragment. Digoxigenin-labeled riboprobes were 
synthesized using in vitro transcription. Paraformaldehyde-fixed (4%, wt/vol) frozen brains 
from E12–14 embryos were sectioned at 20 μm, treated with proteinase K (0.5 μg ml−1), 
acetylated, dehydrated according to standard protocols and hybridized with digoxigenin-
labeled riboprobes (1 μg ml−1) for 18 h at 65 °C. Then, the tissue sections were rinsed and 
incubated with a 1:2,000 dilution of alkaline phosphatase–conjugated sheep antibody to 
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digoxigenin (Roche) in blocking buffer for 3 h at 20–25 °C and developed using nitro-blue 
tetrazolium chloride and 5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt according to 
the manufacturer’s instructions. After developing, alkaline phosphatase activity was 
quenched by fixation in 4% paraformaldehyde and slides containing tissue sections were 
mounted in Aquatex (EM Science Harleco).
Statistical analysis
For examining tissue sections, we used six E12–16 mice for each experiment (control mice, 
n = 3; Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre mice, n = 3). Random fields chosen from more 
than ten tissue sections from each embryo were examined. For assessing cultured 
progenitors and neurons, more than 20 random fields from three mice were analyzed for 
each condition. Statistical significance was determined using an independent t test and one-
way ANOVA followed by Tukey’s post hoc test. Data are presented as means ± s.e.m.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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GSK-3 deletion leads to a massive increase in neural progenitor proliferation. (a) Neural 
progenitor pools are massively expanded in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre (KO) mice. 
Sections of developing forebrain and spinal cord at E13.5 were immunostained with an 
antibody to Sox2. Left, neural progenitor pools were heavily expanded throughout the 
cerebral cortex and ventral area in the Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain sections. 
Scale bar represents 900 μm. Middle, high-magnification image of cerebral cortex 
immunostained for Sox2. Scale bar represents 10 μm. Right, the central canal was closed as 
a result of progenitor hyperproliferation in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre spinal cord 
and there was extension of progenitors into the developing dorsal horn. Scale bar represents 
200 μm. (b) Enhanced progenitor division in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains. 
The numbers of phospho-histone H3– and BrdU-positive dividing cells were increased in the 
sections of Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cerebral cortex at E13.5 compared with 
controls. The phospho-histone H3–labeled mitotic cells were mostly near ventricles in 
control sections. They were not limited in ventricular region, but rather spread throughout 
the developing cortical wall in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre sections. Scale bars 
represent 50 μm (left panels) and 100 μm (right panels). (c) Quantification of mitotic, BrdU 
labeling, cell cycle re-entry and apoptosis indices. n = 10 sections from each of three 
mutants and control embryos per each condition. * P < 0.01.
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Conversion of radial progenitors to INPs is suppressed by GSK-3 deletion. (a) The number 
of Tbr2-positive INPs was markedly reduced in the Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre 
brain sections. E13.5 cerebral cortex samples from controls and Gsk3a−/−; Gsk3bloxP/loxP; 
nestin-cre mice were immunostained with an antibody to Tbr2. Nuclei were counterstained 
with DAPI. Right panels show higher magnification of small boxes (white dotted) in left 
panels. Scale bars represent 50 μm (left panels) and 20 μm (right panels). (b) Western 
blotting showed that the level of Tbr2 was markedly reduced in the Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre brain tissues.
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GSK-3 deletion in progenitors strongly inhibits neurogenesis. (a) Marked thinning of 
cortical areas filled with Tuj1-positive cells in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain 
sections at E13.5. Scale bar represents 500 μm. (b) This was also observed with Tbr1, a 
deeper- layer neuron marker, staining. Scale bar represents 50 μm. (c) NeuN-positive 
neurons were also markedly less frequent in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cortical 
sections. Scale bar represents 100 μm. (d) Quantification of Tuj1-, Sox2-, Tbr1- and NeuN-
positive cells. The ratios of Tuj1-, Sox2- and Tbr1-positive cells to the DAPI-stained cells 
per field were measured and shown as relative change versus control. Relative changes of 
NeuN-positive areas in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre tissue samples were scored by 
measuring NeuN-positive areas with ImageJ software. n = 10 sections from each of three 
mutant and control embryos per each condition. * P < 0.01. (e) Western blotting showed that 
the neuronal makers Tuj1, MAP2, SMI32 and NeuN were downregulated in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre brain tissues. However, the progenitor markers Nestin and Pax6 
were upregulated. Tissue lysates from three mutant and control brains per each condition 
were used. (f) Quantification of western blot data. We used three independent blots from 
each condition for quantification.
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Neurogenesis is inhibited through E15.5. (a–d) The neural progenitor pool was massively 
expanded throughout the rostro-caudal neuraxis in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre 
mice. Serial brain sections in the rostro-caudal direction were prepared from E15.5 mice and 
were immunostained for Sox2 (green) and Tuj1 (red). Scale bar represents 400 μm. Rostral 
brain sections are shown in a and b, and caudal brain sections are shown in c and d. (e,f) 
Higher magnification showed that Sox2-positive progenitor pools in GSK-3 mutant cortex 
were even more expanded at E15.5 than at earlier ages. Generation of Tuj1-positive neurons 
was severely inhibited through this stage. Scale bar represents 100 μm. Left, control brain 
sections. Right, Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre sections.
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Dysregulation of β-catenin and Shh signaling components as a result of GSK-3 deletion. (a) 
Spatial expression of β-catenin was disrupted in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain 
sections. Left, expression of β-catenin was highly enriched along the apical surface of 
control cortical sections (arrow heads). In mutants, β-catenin was highly expressed 
throughout the developing cerebral cortical wall. Right, higher-magnification images 
showing that β-catenin in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre sections was present in both 
the nucleus and cytosol. Scale bars represent 20 μm (left) and 5 μm (right). (b) Western blots 
showed that the expression of β-catenin and its target genes, including Axin2 and c-Jun, 
were increased in the Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains. (c) There were marked 
increases in Gli1 and Gli2 protein levels in the Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains. 
(d) Shh signaling was enhanced in E14 Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain sections. 
Left, Gli1 mRNAs were expressed at low levels in E14 dorsal telencephalon controls. There 
was a significant induction of Gli1 in the ventricular and subventricular regions of Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre samples (arrows). Scale bar represents 100 μm. Middle, there was 
a marked induction of Gli1 mRNA levels in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre ventral 
telencephalon (arrows). Scale bar represents 200 μm. Right, Patched mRNA in control 
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tissues was expressed in the dorsal part of the ventral telencephalon. Ventral telencephalic 
expression of Patched mRNAs in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brains was markedly 
increased (arrows). Scale bar represents 150 μm. SVZ, subventricular zone; VZ, ventricular 
zone. (e) Quantification of western blot data. Three independent blots per each condition 
were used for quantification. * P < 0.01.
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Changes in Notch signaling components and contributions of β-catenin and Notch signaling 
to GSK-3 deletion effects. (a) Expanded zone of Hes1 expression in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre brains. Left, in control brain sections at E14, Hes1 was mostly 
expressed in the ventricular and subventricular zone, where progenitors are normally 
located. However, Hes1 was distributed throughout the developing cortical wall in Gsk3a−/−; 
Gsk3bloxP/loxP; nestin-cre cerebral cortex. Middle, higher magnification of small boxes (red) 
from the left panels. Right, Hes1-stained fields were merged with DAPI-stained images. 
Scale bar represents 150 μm. (b) Western blotting showed that the level of Hes1 and Hes5 
were significantly increased in the Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain lysates. (c) The 
level of NICD was markedly increased in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre brain lysates. 
(d) Inhibition of either β-catenin signaling or Notch signaling partially blocked proliferation 
of Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cortical progenitors in culture. GSK-3 mutant cells 
were transfected with dnTCF, dnHes or control gfp. Cells were then cultured for 48 h and 
immunostained with antibody to Ki67. Overexpressing both dnTCF and dnHes suppressed 
proliferation of GSK-3 mutant progenitors to a higher degree than overexpression of either 
dnTCF or dnHes alone. Scale bar represents 25 μm. Arrows indicate transfected cells that 
were also positive for Ki67. (e) The percentages of Ki67- and GFP-positive cells relative to 
total transfected cells (GFP positive) were counted for quantification. * P < 0.01 (versus 
GFP), ** P < 0.01 (versus dnTCF or dnHes).
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GSK-3 mediates FGF-PI3K signaling to regulate c-Myc in neural progenitors. (a) Compared 
with control progenitors, c-Myc levels were massively increased in nuclei (white dotted 
circle) of Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre progenitors at E14. Scale bar represents 5 μm. 
(b) Western blots showed that levels of c-Myc and N-Myc were increased in GSK-3 mutant 
brain lysates. In contrast, phospho–c-Myc was barely detectable in GSK-3 mutant brains. (c) 
FGF effects on progenitor proliferation were mediated in part by PI3K and GSK-3. Cortical 
progenitors from control and GSK-3 mutant tissues were cultured with either FGF2 alone or 
FGF2 and LY29400 (LY) for 24 h. Then, the cultures were treated with BrdU for 6 h and 
immunostained with an antibody to BrdU. Treatment with FGF increased progenitor 
proliferation in control cultures and PI3K inhibited the FGF2 effects. GSK-3 mutant 
progenitors showed no response to LY29400. Scale bar represents 70 μm. (d) The 
percentage of BrdU-positive cells was counted for quantification. * P < 0.01. (e) GSK-3 
mediated PI3K regulation of c-Myc. Changes in c-Myc expression with LY294002 treatment 
were abrogated in Gsk3a−/−; Gsk3bloxP/loxP; nestin-cre cortical cultures. The decrease in 
phospho-AKT and phospho–GSK-3β showed the efficiency of PI3K inhibition. (f) GSK-3 
mediated the effects of FGF signaling on c-Myc regulation. Western blots showed that the 
addition of a recombinant human basic FGF2 (10 ng ml−1) in control cultures markedly 
induced upregulation of c-Myc, which was suppressed by LY294002 treatment. However, 
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neither the upregulation by FGF2 nor its suppression by LY294002 were observed in Gsk3a
−/−; Gsk3bloxP/loxP; nestin-cre cortical cultures.
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